SFr. 255.00
€ 275.40


vorbestellen

Artikel-Nr. 42835016


Diesen Artikel in meine
Wunschliste
Diesen Artikel
weiterempfehlen
Diesen Preis
beobachten

Weitersagen:


Herausgeber: 
  • Sushama Talegaonkar
  • Dalapathi Gugulothu
  • Kumar Lalit
  • Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy 
     

    (Buch)
    Dieser Artikel gilt, aufgrund seiner Grösse, beim Versand als 3 Artikel!


    Übersicht

    Auf mobile öffnen
     
    Lieferstatus:   Vorankündigung
    Veröffentlichung:  ANGEKÜNDIGT (August 2026)  
    Genre:  Naturwissensch., Medizin, Technik 
     
    BUSINESS & ECONOMICS / Industries / Pharmaceutical & Biotechnology / cancer therapy / Enzyme Inhibition / Manufacturing industries / MEDICAL / Pharmacology / molecular targets / Nanotechnology / Pharmaceutical industries
    ISBN:  9780443438462 
    EAN-Code: 
    9780443438462 
    Verlag:  Elsevier 
    Einband:  Kartoniert  
    Sprache:  English  
    Dimensionen:  H 235 mm / B 191 mm / D  
    Gewicht:  450 gr 
    Bewertung: Keine Bewertung vor Veröffentlichung möglich.
    Inhalt:
    Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy presents a rigorous examination of advanced strategies for the selective targeting of neoplastic cells and their distinct microenvironments. This comprehensive volume elucidates both tissue-specific and tumor-specific molecular targets, clarifying how these methodologies can significantly enhance therapeutic precision while mitigating off-target effects. The initial section of the text provides an in-depth analysis of tissue-specific regulatory targets across various organs, including the liver, lungs, brain, skin, and bones. It delineates the critical mediators and mechanisms that govern tumor immunity, thereby identifying novel therapeutic avenues.

    Each chapter meticulously evaluates key regulatory molecules such as TGF-ss, CTLA-4, and IL-10, exploring their roles in tumorigenesis and the potential for targeted interventions across a spectrum of malignancies. Subsequent sections focus on tumor tissue-specific molecular targets, encompassing immunological checkpoints, growth factors, and signaling pathways pertinent to cancers of the liver, stomach, ovary, prostate, and colon. The text provides insights into the application of monoclonal antibodies and molecular inhibitors as strategies to impede cancer progression and address therapeutic resistance. Concluding chapters address emerging therapeutic paradigms, including precision medicine and nanotechnology.

      



    Wird aktuell angeschaut...
     

    Zurück zur letzten Ansicht


    AGB | Datenschutzerklärung | Mein Konto | Impressum | Partnerprogramm
    Newsletter | 1Advd.ch RSS News-Feed Newsfeed | 1Advd.ch Facebook-Page Facebook | 1Advd.ch Twitter-Page Twitter
    Forbidden Planet AG © 1999-2026
    Alle Angaben ohne Gewähr
     
    SUCHEN

     
     Kategorien
    Im Sortiment stöbern
    Genres
    Hörbücher
    Aktionen
     Infos
    Mein Konto
    Warenkorb
    Meine Wunschliste
     Kundenservice
    Recherchedienst
    Fragen / AGB / Kontakt
    Partnerprogramm
    Impressum
    © by Forbidden Planet AG 1999-2026